Drug information for ASPIRIN AND DIPYRIDAMOLE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CAPSULE, EXTENDED RELEASE; ORAL
25MG;200MG
Prescription
AB
ASPIRIN
;
DIPYRIDAMOLE
aspirin, dipyridamole drug combination
BARR
78804
2009-08-21 Letter
Drug Adverse Effects information for ASPIRIN AND DIPYRIDAMOLE
Role code
Indications
Reaction
# Reports
SS
ATRIAL FLUTTER
DUODENAL ULCER
1
SS
ATRIAL FLUTTER
HAEMOGLOBIN DECREASED
1
SS
ATRIAL FLUTTER
MELAENA
1
SS
ATRIAL FLUTTER
PLATELET COUNT INCREASED
1
SS
BLOOD HOMOCYSTEINE INCREASED
DUODENAL ULCER
1
SS
BLOOD HOMOCYSTEINE INCREASED
HAEMOGLOBIN DECREASED
1
SS
BLOOD HOMOCYSTEINE INCREASED
MELAENA
1
SS
BLOOD HOMOCYSTEINE INCREASED
PLATELET COUNT INCREASED
1
SS
CEREBROVASCULAR ACCIDENT
GASTRIC HAEMORRHAGE
1
SS
DUODENAL ULCER
DUODENAL ULCER
1
SS
DUODENAL ULCER
HAEMOGLOBIN DECREASED
1
SS
DUODENAL ULCER
MELAENA
1
SS
DUODENAL ULCER
PLATELET COUNT INCREASED
1
SS
PAIN
DUODENAL ULCER
1
SS
PAIN
GASTRIC HAEMORRHAGE
1
SS
PAIN
HAEMOGLOBIN DECREASED
1
SS
PAIN
MELAENA
1
SS
PAIN
PLATELET COUNT INCREASED
1
SS
PROPHYLAXIS
DUODENAL ULCER
1
SS
PROPHYLAXIS
GASTRIC HAEMORRHAGE
1
SS
PROPHYLAXIS
HAEMOGLOBIN DECREASED
1
SS
PROPHYLAXIS
MELAENA
1
SS
PROPHYLAXIS
PLATELET COUNT INCREASED
1
C
BLOOD FOLATE DECREASED
CEREBROVASCULAR ACCIDENT
1
C
CHRONIC MYELOID LEUKAEMIA
ACUTE MYOCARDIAL INFARCTION
1
C
CHRONIC MYELOID LEUKAEMIA
ANGINA PECTORIS
1
C
CHRONIC MYELOID LEUKAEMIA
CHEST DISCOMFORT
1
C
CHRONIC MYELOID LEUKAEMIA
CHEST PAIN
1
C
CHRONIC MYELOID LEUKAEMIA
DYSPNOEA EXERTIONAL
1
C
CHRONIC MYELOID LEUKAEMIA
FATIGUE
1
C
CHRONIC MYELOID LEUKAEMIA
LIMB DISCOMFORT
1
C
CHRONIC MYELOID LEUKAEMIA
MUSCULOSKELETAL PAIN
1
C
CHRONIC MYELOID LEUKAEMIA
MYOCARDIAL ISCHAEMIA
1
C
CHRONIC MYELOID LEUKAEMIA
PERIPHERAL VASCULAR DISORDER
1
C
DIABETES MELLITUS
DRUG INTERACTION
3
C
DIABETES MELLITUS
FALL
3
C
DIABETES MELLITUS
NAUSEA
3
C
DIABETES MELLITUS
OEDEMA
3
C
DIABETES MELLITUS
VOMITING
3
C
DIABETES MELLITUS
WEIGHT DECREASED
3
C
DYSPEPSIA
CEREBROVASCULAR ACCIDENT
1
C
HYPERTENSION
CEREBROVASCULAR ACCIDENT
2
C
IRON DEFICIENCY
DRUG INTERACTION
2
C
IRON DEFICIENCY
FALL
2
C
IRON DEFICIENCY
NAUSEA
2
C
IRON DEFICIENCY
OEDEMA
2
C
IRON DEFICIENCY
VOMITING
2
C
IRON DEFICIENCY
WEIGHT DECREASED
2
C
MACULAR DEGENERATION
CEREBROVASCULAR ACCIDENT
1
C
PARKINSON'S DISEASE
DRUG INTERACTION
13
C
PARKINSON'S DISEASE
FALL
13
C
PARKINSON'S DISEASE
NAUSEA
13
C
PARKINSON'S DISEASE
OEDEMA
13
C
PARKINSON'S DISEASE
VOMITING
13
C
PARKINSON'S DISEASE
WEIGHT DECREASED
13
C
PERNICIOUS ANAEMIA
DRUG INTERACTION
3
C
PERNICIOUS ANAEMIA
FALL
3
C
PERNICIOUS ANAEMIA
NAUSEA
3
C
PERNICIOUS ANAEMIA
OEDEMA
3
C
PERNICIOUS ANAEMIA
VOMITING
3
C
PERNICIOUS ANAEMIA
WEIGHT DECREASED
3
C
PRODUCT USED FOR UNKNOWN INDICATION
CEREBROVASCULAR ACCIDENT
1
C
PRODUCT USED FOR UNKNOWN INDICATION
DRUG INTERACTION
1
C
PRODUCT USED FOR UNKNOWN INDICATION
FALL
1
C
PRODUCT USED FOR UNKNOWN INDICATION
NAUSEA
1
C
PRODUCT USED FOR UNKNOWN INDICATION
OEDEMA
1
C
PRODUCT USED FOR UNKNOWN INDICATION
VOMITING
1
C
PRODUCT USED FOR UNKNOWN INDICATION
WEIGHT DECREASED
1
C
TRANSIENT ISCHAEMIC ATTACK
CEREBROVASCULAR ACCIDENT
2
C
TYPE 2 DIABETES MELLITUS
URTICARIA
2
C
TYPE 2 DIABETES MELLITUS
VOMITING
2
Ads by Google